1. Home
  2. ASTC vs GLMD Comparison

ASTC vs GLMD Comparison

Compare ASTC & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrotech Corporation (DE)

ASTC

Astrotech Corporation (DE)

HOLD

Current Price

$3.28

Market Cap

5.9M

Sector

Industrials

ML Signal

HOLD

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

HOLD

Current Price

$0.97

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTC
GLMD
Founded
1984
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.6M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ASTC
GLMD
Price
$3.28
$0.97
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.0K
6.3M
Earning Date
11-13-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,312,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.06
N/A
52 Week Low
$2.47
$0.74
52 Week High
$8.15
$3.61

Technical Indicators

Market Signals
Indicator
ASTC
GLMD
Relative Strength Index (RSI) 44.37 40.09
Support Level $2.47 $0.81
Resistance Level $3.29 $0.94
Average True Range (ATR) 0.20 0.13
MACD 0.05 0.00
Stochastic Oscillator 80.30 28.86

Price Performance

Historical Comparison
ASTC
GLMD

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Share on Social Networks: